Cargando…
The Role of Targeted Focal Therapy in the Management of Low-Risk Prostate Cancer: Update on Current Challenges
Prostate cancer is one of the most prevalent cancers among men in the United States, second only to nonmelanomatous skin cancer. Since prostate-specific antigen (PSA) testing came into widespread use in the late 1980s, there has been a sharp increase in annual prostate cancer incidence. Cancer-speci...
Autores principales: | Smith, Daniel W., Stoimenova, Diliana, Eid, Khadijah, Barqawi, Al |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549346/ https://www.ncbi.nlm.nih.gov/pubmed/23346405 http://dx.doi.org/10.1155/2012/587139 |
Ejemplares similares
-
Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy
por: Barqawi, Al B., et al.
Publicado: (2012) -
The Accuracy of Prostate Cancer Localization Diagnosed on Transrectal Ultrasound-Guided Biopsy Compared to 3-Dimensional Transperineal Approach
por: Krughoff, Kevin, et al.
Publicado: (2013) -
Focal therapy in prostate cancer: the current situation
por: Jácome-Pita, FX, et al.
Publicado: (2014) -
Focal therapy for prostate cancer: The current status
por: Marshall, Susan, et al.
Publicado: (2015) -
Focal therapy for prostate cancer: the technical challenges
por: Haworth, Annette, et al.
Publicado: (2017)